Samil Pharmaceutical Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1946-01-01
- Employees
- 568
- Market Cap
- -
- Website
- http://www.samil-pharm.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Diseases of the Circulatory SystemEssential Hypertension
- Interventions
- First Posted Date
- 2015-10-19
- Last Posted Date
- 2015-10-19
- Lead Sponsor
- Samil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT02579356
- Locations
- 🇰🇷
Chonbuk National University Hospital, Seoul, Korea, Republic of
News
No news found